Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWarrillow, Stephen J-
dc.contributor.authorFisher, Caleb-
dc.contributor.authorTibballs, Heath-
dc.contributor.authorBailey, Michael-
dc.contributor.authorMcArthur, Colin-
dc.contributor.authorLawson-Smith, Pia-
dc.contributor.authorPrasad, Bheemasenachar-
dc.contributor.authorAnstey, Matthew-
dc.contributor.authorVenkatesh, Bala-
dc.contributor.authorDashwood, Gemma-
dc.contributor.authorWalsham, James-
dc.contributor.authorHolt, Andrew-
dc.contributor.authorWiersema, Ubbo-
dc.contributor.authorGattas, David-
dc.contributor.authorZoeller, Matthew-
dc.contributor.authorGarcia Alvarez, Mercedes-
dc.contributor.authorBellomo, Rinaldo-
dc.identifier.citationJournal of Gastroenterology and Hepatology 2020; 35(5): 846-854-
dc.description.abstractTo study the management of coagulation and hematological derangements among severe acute liver failure (ALF) patients in Australia and New Zealand liver transplant intensive care units (ICUs). Analysis of key baseline characteristics, etiology, coagulation and hematological tests, use of blood products, thrombotic complications, and clinical outcomes during the first ICU week. We studied 62 ALF patients. The first day median peak international normalized ratio was 5.5 (inter-quartile range [IQR] 3.8-8.7), median longest activated partial thromboplastin time was 62 s (IQR 44-87), and median lowest fibrinogen was 1.1 (IQR 0.8-1.6) g/L. Fibrinogen was only measured in 85% of patients, which was less than other tests (P < 0.0001). Median initial lowest platelet count was 83 (IQR 41-122) × 109 /L. Overall, 58% of patients received fresh frozen plasma, 40% cryoprecipitate, 35% platelets, and 15% prothrombin complex concentrate. Patients with bleeding complications (19%) had more severe overall hypofibrinogenemia and thrombocytopenia. Thrombotic complications were less common (10% of patients), were not associated with consistent patterns of abnormal hemostasis, and were not immediately preceded by clotting factor administration and half occurred only after liver transplantation surgery. In ALF patients admitted to dedicated Australia and New Zealand ICUs, fibrinogen was measured less frequently than other coagulation parameters but, together with platelets, appeared more relevant to bleeding risk. Blood products and procoagulant factors were administered to most patients at variable levels of hemostatic derangement, and bleeding complications were more common than thrombotic complications. This epidemiologic information and practice variability provide baseline data for the design and powering of interventional studies.-
dc.subjectacute liver failure-
dc.subjectencephalopathy emergency liver transplant-
dc.titleCoagulation abnormalities, bleeding, thrombosis, and management of patients with acute liver failure in Australia and New Zealand.-
dc.typeJournal Article-
dc.identifier.journaltitleJournal of Gastroenterology and Hepatology-
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, Monash University School of Public Health and Preventive Medicine, Victoria, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Intensive Care, Royal Prince Alfred Hospital, Sydney, Australiaen
dc.identifier.affiliationDepartment of Critical Care Medicine, Auckland City Hospital, Auckland, New Zealanden
dc.identifier.affiliationDepartment of Intensive Care, Princess Alexandra Hospital, Brisbane, Australiaen
dc.identifier.affiliationDepartment of Intensive Care, Sir Charles Gairdner Hospital, Perth, Western Australia, Australiaen
dc.identifier.affiliationIntensive Care-
dc.identifier.affiliationSouth Metropolitan Health Service, Rockingham, Western Australia, Australiaen
dc.identifier.affiliationDepartment of Medicine and Surgery, The University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationMedical Research Institute of New Zealand, Auckland, New Zealanden
dc.identifier.affiliationCentre for Integrated Critical Care, The University of Melbourne, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Intensive Care, Royal Melbourne Hospital, Melbourne, Australiaen
dc.identifier.affiliationDepartment of Intensive Care, Flinders Medical Centre, Adelaide, South Australia, Australiaen
dc.identifier.affiliationDepartment of Anesthesiology and Pain Medicine, Hospital Santa Creu i Sant Pau, University of Barcelona, Barcelona, Spain-
dc.identifier.affiliationData Analytics Research and Evaluation (DARE) Centre, Austin Health and The University of Melbourne, Heidelberg, Victoria, Australia-
dc.type.austinJournal Article-, Rinaldo
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.languageiso639-1en- Care- Care- Care- Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jun 14, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.